JPH1077292A5 - - Google Patents

Info

Publication number
JPH1077292A5
JPH1077292A5 JP1997222854A JP22285497A JPH1077292A5 JP H1077292 A5 JPH1077292 A5 JP H1077292A5 JP 1997222854 A JP1997222854 A JP 1997222854A JP 22285497 A JP22285497 A JP 22285497A JP H1077292 A5 JPH1077292 A5 JP H1077292A5
Authority
JP
Japan
Prior art keywords
androstane
diol
dione
dimethylaminoethoxyimino
dimethylaminopropoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997222854A
Other languages
English (en)
Japanese (ja)
Other versions
JP4297994B2 (ja
JPH1077292A (ja
Filing date
Publication date
Priority claimed from DE19633349A external-priority patent/DE19633349A1/de
Application filed filed Critical
Publication of JPH1077292A publication Critical patent/JPH1077292A/ja
Publication of JPH1077292A5 publication Critical patent/JPH1077292A5/ja
Application granted granted Critical
Publication of JP4297994B2 publication Critical patent/JP4297994B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP22285497A 1996-08-19 1997-08-19 心臓血管系に活性のある新規の6−ヒドロキシおよび6−オキソ−アンドロスタン誘導体およびそれらを含有する製薬用組成物 Expired - Lifetime JP4297994B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19633349A DE19633349A1 (de) 1996-08-19 1996-08-19 Neue 6-Hydroxy- und 6-Oxo-androstan-Derivate, die auf das kardiovaskuläre System wirken und pharmazeutische Zusammensetzungen, die diese enthalten
DE19633349.0 1996-08-19

Publications (3)

Publication Number Publication Date
JPH1077292A JPH1077292A (ja) 1998-03-24
JPH1077292A5 true JPH1077292A5 (enExample) 2005-05-19
JP4297994B2 JP4297994B2 (ja) 2009-07-15

Family

ID=7802998

Family Applications (1)

Application Number Title Priority Date Filing Date
JP22285497A Expired - Lifetime JP4297994B2 (ja) 1996-08-19 1997-08-19 心臓血管系に活性のある新規の6−ヒドロキシおよび6−オキソ−アンドロスタン誘導体およびそれらを含有する製薬用組成物

Country Status (9)

Country Link
US (1) US5914324A (enExample)
EP (1) EP0825197B1 (enExample)
JP (1) JP4297994B2 (enExample)
AT (1) ATE196768T1 (enExample)
DE (2) DE19633349A1 (enExample)
DK (1) DK0825197T3 (enExample)
ES (1) ES2151698T3 (enExample)
GR (1) GR3034821T3 (enExample)
PT (1) PT825197E (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1317031B1 (it) * 2000-05-17 2003-05-26 Sigma Tau Ind Farmaceuti Procedimento migliorato per la preparazione di (e,z)3-(2-amminoetossimmino)-androstano-6, 17-dione e di suoi analoghi.
US8168621B2 (en) 2005-09-30 2012-05-01 Endece, Llc 6-substituted estradiol derivatives and methods of use
US10174070B2 (en) 2005-09-30 2019-01-08 Endece Llc 6-substituted estradiol derivatives and methods of use
US20080119447A1 (en) * 2005-09-30 2008-05-22 James Yarger 6-alkoxyalkyl estradiol derivatives and methods of use
TWI392682B (zh) 2006-04-13 2013-04-11 Sigma Tau Ind Farmaceuti 作為心血管疾病的治療藥物之雄甾烷和雄甾烯的胺基衍生物
TWI389917B (zh) * 2006-04-13 2013-03-21 Sigma Tau Ind Farmaceuti 作為心血管疾病治療藥物的雄甾烷與雄甾烯之氮雜環烷基衍生物
TWI372762B (en) * 2006-06-23 2012-09-21 Sigma Tau Ind Farmaceuti Amino derivatives of b-homoandrostanes and b-heteroandrostanes
WO2008067450A2 (en) 2006-11-30 2008-06-05 Endece, Llc 6-alkoxyalkyl estradiol derivatives and methods of use
US8664210B2 (en) * 2007-10-12 2014-03-04 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Aminooxime derivatives of 2- and/or 4-substituted androstanes and androstenes as medicaments for cardiovascular disorders
WO2010149666A1 (en) 2009-06-22 2010-12-29 Medexis S.A. Methods for treating neoplasia
WO2012013816A1 (en) * 2010-07-30 2012-02-02 Medexis S.A. Compounds and methods for treating neoplasia
ES2605960T3 (es) 2010-09-14 2017-03-17 Endece, Llc Derivados de desmetil-estradiol 6-sustituido como agonistas del RE-beta
CN103315968B (zh) * 2013-06-26 2015-04-01 中国生命药物治疗有限公司 一种注射用粉针剂及其制备方法
CN103360457B (zh) * 2013-07-31 2015-10-07 中国生命药物治疗有限公司 一种雄甾烷二酮衍生物晶型及其制备方法
PL3599243T3 (pl) 2018-07-26 2023-08-21 Cvie Therapeutics Limited Związki podobne do 17beta-heterocyklilu naparstnicy do leczenia niewydolności serca
BR112021017009A2 (pt) 2019-03-05 2021-11-09 Windtree Therapeutics Inc Formulação intravenosa contendo istaroxima para o tratamento da insuficiência cardíaca aguda (ahf)
ES2970792T3 (es) 2019-10-09 2024-05-30 Windtree Therapeutics Inc Derivados de androstano con actividad como estimuladores puros o predominantemente puros de SERCA2A para el tratamiento de la insuficiencia cardíaca

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2863885A (en) * 1958-02-10 1958-12-09 Upjohn Co 17-isonitrosoandrostanes
FR7725M (enExample) * 1967-06-22 1970-03-02
CH504427A (de) * 1967-12-06 1971-03-15 Ciba Geigy Ag Verfahren zur Herstellung neuer 4-Imino-19-nor-A-homosteroid-triene
US5144017A (en) * 1988-07-13 1992-09-01 University Of Manitoba Compounds that bind to digitalis receptor
GB9201224D0 (en) * 1992-01-21 1992-03-11 Erba Carlo Spa Difluoromethylenandrostenone derivatives and process for their preparation
DE4227605C2 (de) * 1992-08-20 1995-02-16 Sigma Tau Ind Farmaceuti 17-Hydroxyiminomethyl-14beta-hydroxy-5ß-androstan-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die dieselben enthalten
DE4232656C2 (de) * 1992-09-29 1995-01-12 Sigma Tau Ind Farmaceuti Cyclopentanperhydrophenanthren-17-furyl-3ß-derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutischen Zusammensetzungen
DE4344236A1 (de) * 1993-12-23 1995-06-29 Sigma Tau Ind Farmaceuti Neue 17-Iminomethylalkenyl-5beta,14beta-androstan- und 17-Iminoalkyl-5beta,14beta-androstan-Derivate , die auf das kardiovaskuläre System wirken, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten

Similar Documents

Publication Publication Date Title
JPH1077292A5 (enExample)
JPWO2020123827A5 (enExample)
RU2008106058A (ru) Производные пиридазинона в качестве агонистов рецептора тиреоидного гормона
US20120232042A1 (en) 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylene phenyl derivatives, methods for the production thereof and use thereof for treating diseases
JP2004507519A5 (enExample)
JP2006509749A5 (enExample)
JP2006182786A5 (enExample)
EP2067784A3 (en) 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivatives as anti-inflammatory agents
JP2006515587A5 (enExample)
JP2004516314A5 (enExample)
JP2006512301A5 (enExample)
JP2002502874A5 (enExample)
JP2018135343A5 (enExample)
JP2005519991A5 (enExample)
RU95117585A (ru) ПРОИЗВОДНЫЕ ГИДРИРОВАННЫХ ПИРИДО(4,3-b)ИНДОЛОВ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И СПОСОБ ЛЕЧЕНИЯ
RU94020400A (ru) Производные индола, способ их получения, фармацевтическая композиция, способ лечения головной боли
JP2009533392A5 (enExample)
DE69323322D1 (de) Verwendung dimethylbenzofuran und dimethylbenzopyran derivate als 5-ht3 antagoniste
JPH1036365A5 (enExample)
JP2020509043A5 (enExample)
JP2008542386A5 (enExample)
JPWO2023091787A5 (enExample)
JP2003521457A5 (enExample)
KR940005661A (ko) 심장혈관계 질환에 유효한 신규17-하이디록시이미노메틸-14β-하이드록시-5β-안드로스탄 유도체와 이들의 제조방법 및 약제학적 조성물
JP2009506113A5 (enExample)